If you made any changes in Pure these will be visible here soon.

Research Output 2006 2019

2019

Combining BH3-Mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

Moujalled, D. M., Pomilio, G., Ghiurau, C., Ivey, A., Salmon, J., Rijal, S., Macraild, S., Zhang, L., Teh, T. C., Tiong, I. S., Lan, P., Chanrion, M., Claperon, A., Rocchetti, F., Zichi, A., Kraus-Berthier, L., Wang, Y., Halilovic, E., Morris, E., Colland, F. & 7 othersSegal, D., Huang, D., Roberts, A. W., Maragno, A. L., Lessene, G., Geneste, O. & Wei, A. H., 1 Apr 2019, In : Leukemia. 33, a, p. 905-917 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Correction: High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia (Blood Cancer Journal, (2018), 8, 8, (68), 10.1038/s41408-018-0103-6)

Marquis, M., Beaubois, C., Lavallée, V. P., Abrahamowicz, M., Danieli, C., Lemieux, S., Ahmad, I., Wei, A., Ting, S. B., Fleming, S., Schwarer, A., Grimwade, D., Grey, W., Hills, R. K., Vyas, P., Russell, N., Sauvageau, G. & Hébert, J., 1 Mar 2019, In : Blood Cancer Journal. 9, 3, 1 p., 28.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

Genomic subtyping and therapeutic targeting of acute erythroleukemia

Iacobucci, I., Wen, J., Meggendorfer, M., Choi, J. K., Shi, L., Pounds, S. B., Carmichael, C. L., Masih, K. E., Morris, S. M., Lindsley, R. C., Janke, L. J., Alexander, T. B., Song, G., Qu, C., Li, Y., Payne-Turner, D., Tomizawa, D., Kiyokawa, N., Valentine, M., Valentine, V. & 28 othersBasso, G., Locatelli, F., Enemark, E. J., Kham, S. K. Y., Yeoh, A. E. J., Ma, X., Zhou, X., Sioson, E., Rusch, M., Ries, R. E., Stieglitz, E., Hunger, S. P., Wei, A. H., To, L. B., Lewis, I. D., D’Andrea, R. J., Kile, B. T., Brown, A. L., Scott, H. S., Hahn, C. N., Marlton, P., Pei, D., Cheng, C., Loh, M. L., Ebert, B. L., Meshinchi, S., Haferlach, T. & Mullighan, C. G., Apr 2019, In : Nature Genetics. 51, 4, p. 694-704 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia

McKenzie, M. D., Ghisi, M., Oxley, E. P., Ngo, S., Cimmino, L., Esnault, C., Liu, R., Salmon, J. M., Bell, C. C., Ahmed, N., Erlichster, M., Witkowski, M. T., Liu, G. J., Chopin, M., Dakic, A., Simankowicz, E., Pomilio, G., Vu, T., Krsmanovic, P., Su, S. & 21 othersTian, L., Baldwin, T. M., Zalcenstein, D. A., DiRago, L., Wang, S., Metcalf, D., Johnstone, R. W., Croker, B. A., Lancaster, G. I., Murphy, A. J., Naik, S. H., Nutt, S. L., Pospisil, V., Schroeder, T., Wall, M., Dawson, M. A., Wei, A. H., de Thé, H., Ritchie, M. E., Zuber, J. & Dickins, R. A., 1 Aug 2019, In : Cell Stem Cell. 25, 2, p. 258-272.e9 24 p.

Research output: Contribution to journalArticleResearchpeer-review

2018

AMG 176, a selective MCL1 inhibitor, is effective in hematologic cancer models alone and in combination with established therapies

Caenepeel, S., Brown, S. P., Belmontes, B., Moody, G., Keegan, K. S., Chui, D., Whittington, D. A., Huang, X., Poppe, L., Cheng, A. C., Cardozo, M., Houze, J., Li, Y., Lucas, B., Paras, N. A., Wang, X., Taygerly, J. P., Vimolratana, M., Zancanella, M., Zhu, L. & 18 othersCajulis, E., Osgood, T., Sun, J., Damon, L., Egan, R. K., Greninger, P., McClanaghan, J. D., Gong, J., Moujalled, D., Pomilio, G., Beltran, P., Benes, C. H., Roberts, A. W., Huang, D. C., Wei, A., Canon, J., Coxon, A. & Hughes, P. E., 1 Dec 2018, In : Cancer Discovery. 8, 12, p. 1582-1597 16 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies

Tiong, I. S., Reynolds, J., Bradstock, K. F., Seymour, J. F., Wei, A. H. & on behalf of the Australasian Leukaemia & Lymphoma Group, 22 Aug 2018, In : Blood Cancer Journal. 8, 9, 5 p., 84.

Research output: Contribution to journalLetterResearchpeer-review

Open Access
File

Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1

Teh, T. C., Nguyen, N. Y., Moujalled, D. M., Segal, D., Pomilio, G., Rijal, S., Jabbour, A., Cummins, K., Lackovic, K., Blombery, P., Thompson, E., Ekert, P. G., Lessene, G., Glaser, S. P., Huang, D. C. S., Roberts, A. W., Guthridge, M. A. & Wei, A. H., 1 Feb 2018, In : Leukemia. 32, 2, p. 303-312 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Molecular Patterns of Response and Outcome in the Chemotherapy and Venetoclax in Elderly AML Trial (CAVEAT) study. Blood 2018 132:333

Wei, A., Chua, C. C., Tiong, I. S., Fong, C. Y., Ting, S. B. N., Macraild, S., Salmon, J. M., Ivey, A., Nguyen, J., Yuen, F., Fleming, S. A., Bohlander, S., Reynolds, J. & Roberts, A. W., Dec 2018.

Research output: Contribution to conferenceAbstractOtherpeer-review

Open Access

Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia

Tiong, I. S., Tan, P., McManus, J., Cummings, N., Sadawarte, S., Catalano, J., Hills, R. & Wei, A., 2018, In : Leukemia and Lymphoma. 59, 2, p. 493-496 4 p.

Research output: Contribution to journalLetterResearchpeer-review

2017

Accelerating Early Drug Development: Come on Down Under

Wei, A., Jul 2017, In : Annals of Oncology. 28, 7, p. 1655-1657 3 p., mdx101.

Research output: Contribution to journalArticleOtherpeer-review

Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia

Kantarjian, H. M., Stein, A., Gökbuget, N., Fielding, A. K., Schuh, A. C., Ribera, J. M., Wei, A., Dombret, H., Foà, R., Bassan, R., Arslan, Ö., Sanz, M. A., Bergeron, J., Demirkan, F., Lech-Maranda, E., Rambaldi, A., Thomas, X., Horst, H-A., Brüggemann, M., Klapper, W. & 6 othersWood, B. L., Fleishman, A., Nagorsen, D., Holland, C. J., Zimmerman, Z. & Topp, M. S., 2 Mar 2017, In : New England Journal of Medicine. 376, 9, p. 836-847 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Corrigendum to “KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study” [Leuk. Res. 50 (Nov) (2016) 123–131. PubMed PMID: 27736729](S0145212616301989)(10.1016/j.leukres.2016.09.012)

Swords, R. T., Greenberg, P. L., Wei, A. H., Durrant, S., Advani, A. S., Hertzberg, M. S., Lewis, I. D., Rivera, G., Gratzinger, D., Fan, A. C., Felsher, D. W., Cortes, J. E., Watts, J. M., Yarranton, G. T., Walling, J. M. & Lancet, J. E., 1 Aug 2017, In : Leukemia Research. 59, 1 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., Levine, R. L., Lo-Coco, F., Naoe, T., Niederwieser, D., Ossenkoppele, G. J., Sanz, M. A., Sierra, J., Tallman, M. S., Tien, H. F., Wei, A. H. & 2 othersLöwenberg, B. & Bloomfield, C. D., 26 Jan 2017, In : Blood. 129, 4, p. 424-447 24 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia

Bradstock, K. F., Link, E., Di Iulio, J., Szer, J., Marlton, P., Wei, A., Enno, A., Schwarer, A., Lewis, I. D., Rozario, J. D., Coyle, L., Cull, G., Campbell, P., Leahy, M. F., Hahn, U. H., Cannell, P., Tiley, C., Lowenthal, R. M., Moore, J. & Cartwright, K., 20 May 2017, In : Journal of Clinical Oncology. 35, 15, p. 1678 - 1685 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Improving the Transition to Palliative Care for Patients With Acute Leukemia: A Coordinated Care Approach

Hopkins, B., Gold, M., Wei, A. & Grigoriadis, G., May 2017, In : Cancer Nursing. 40, 3, p. E17-E23 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population

Hein, N., Cameron, D. P., Hannan, K. M., Nguyen, N. Y. N., Fong, C. Y., Sornkom, J., Wall, M., Pavy, M., Cullinane, C. M., Diesch, J., Devlin, J. R., George, A. J., Sanij, E., Quin, J. E., Poortinga, G., Verbrugge, I., Baker, A., Drygin, D. J., Harrison, S. J., Rozario, J. D. & 10 othersPowell, J. A., Pitson, S. M., Zuber, J., Johnstone, R. W., Dawson, M. A., Guthridge, M. A., Wei, A., McArthur, G. A., Pearson, R. B. & Hannan, R. D., 25 May 2017, In : Blood. 129, 21, p. 2882-2895 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia

Fleming, S., Ong, D. M., Jackson, K., Avery, S., Mollee, P. N., Marlton, P., Kennedy, G. A. & Wei, A. H., Apr 2017, In : British Journal of Haematology. 177, 2, p. 328-330 3 p.

Research output: Contribution to journalArticleResearchpeer-review

Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia

Powell, J. A., Lewis, A. C., Zhu, W., Toubia, J., Pitman, M. R., Wallington-Beddoe, C. T., Moretti, P. A. B., Iarossi, D., Samaraweera, S. E., Cummings, N., Ramshaw, H. S., Thomas, D., Wei, A. H., Lopez, A. F., D'Andrea, R. J., Lewis, I. D. & Pitson, S. M., 9 Feb 2017, In : Blood. 129, 6, p. 771-782 12 p.

Research output: Contribution to journalArticleResearchpeer-review

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

Tan, P., Tiong, I. S., Fleming, S., Pomilio, G., Cummings, N., Droogleever, M., McManus, J., Schwarer, A., Catalano, J., Patil, S., Avery, S., Spencer, A. & Wei, A., 2017, In : Oncotarget. 8, 32, p. 52269-52280 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

The Patients’ Perspective: Hematological Cancer Patients’ Experiences of Adverse Events as Part of Care

Bryant, J., Carey, M., Sanson-Fisher, R., Turon, H., Wei, A. & Kuss, B., 17 Mar 2017, (Accepted/In press) In : Journal of Patient Safety.

Research output: Contribution to journalArticleResearchpeer-review

Up-Regulation of the Vitamin D Pathway in Acute Myeloid Leukemia: A Novel Cause of Hypercalcemia

Casan, J. M. L., Ghoth, S., Wei, A. H., Ting, S. B. & Morgan, S., 2017, In : Annals of Hematology and Oncology. 4, 3, 1141.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File

‘Did He Who Made the Lamb Make Thee?’ New Developments in Treating the ‘Fearful Symmetry’ of Acute Myeloid Leukemia

Brumatti, G., Lalaoui, N., Wei, A. H. & Silke, J., 1 Mar 2017, In : Trends in Molecular Medicine. 23, 3, p. 264-281 18 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

2016

Correction: Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics (Cancer Cell (2016) 30(3) (499–500) (S1535610816000350) (10.1016/j.ccell.2016.01.006))

Lalaoui, N., Hänggi, K., Brumatti, G., Chau, D., Nguyen, N. Y. N., Vasilikos, L., Spilgies, L. M., Heckmann, D. A., Ma, C., Ghisi, M., Salmon, J. M., Matthews, G. M., de Valle, E., Moujalled, D. M., Menon, M. B., Spall, S. K., Glaser, S. P., Richmond, J., Lock, R. B., Condon, S. M. & 10 othersGugasyan, R., Gaestel, M., Guthridge, M., Johnstone, R. W., Munoz, L., Wei, A., Ekert, P. G., Vaux, D. L., Wong, W. W. L. & Silke, J., 12 Sep 2016, In : Cancer Cell. 30, 3, p. 499-500 2 p.

Research output: Contribution to journalComment / DebateOtherpeer-review

Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia

Roboz, G. J., Montesinos, P., Selleslag, D., Wei, A., Jang, J. H., Falantes, J., Voso, M. T., Sayar, H., Porkka, K., Marlton, P., Almeida, A., Mohan, S., Ravandi, F., Garcia-Manero, G., Skikne, B. & Kantarjian, H. M., 1 Feb 2016, In : Future Oncology. 12, 3, p. 293-302 10 p.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File

Isavuconazole as salvage therapy for mucormycosis

Graves, B., Morrissey, C. O., Wei, A., Coutsouvelis, J., Ellis, S. J., Pham, A., Gooi, J. & Ananda-Rajah, M., 1 Mar 2016, In : Medical Mycology Case Reports. 11, p. 36-39 4 p.

Research output: Contribution to journalArticleOtherpeer-review

Open Access
File

KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study

Swords, R. T., Greenberg, P. L., Wei, A. H., Durrant, S., Advani, A. S., Hertzberg, M. S., Lewis, I. D., Rivera, G., Gratzinger, D., Fan, A. C., Felsher, D. W., Cortes, J. E., Watts, J. M., Yarranton, G. T., Walling, J. M. & Lancet, J. E., 1 Nov 2016, In : Leukemia Research. 50, p. 123-131 9 p.

Research output: Contribution to journalArticleResearchpeer-review

PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia

Guirguis, A., Slape, C. I., Failla, L. M., Saw, J. M. Y., Tremblay, C., Powell, D. R., Rossello, F. J., Wei, A., Strasser, A. & Curtis, D. J., 2016, In : Cell Death and Differentiation. 23, 6, p. 1049 - 1059 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics

Lalaoui, N., Hanggi, K., Brumatti, G., Chau, D., Nguyen, N-Y. N., Vasilikos, L., Spilgies, L. M., Heckmann, D. A., Ma, C., Ghisi, M., Salmon, J. M., Matthews, G. M., de Valle, E., Moujalled, D. M., Menon, M. B., Spall, S. K., Glaser, S. P., Richmond, J., Lock, R. B., Condon, S. M. & 10 othersGugasyan, R., Gaestel, M., Guthridge, M., Johnstone, R. W., Munoz, L., Wei, A., Ekert, P. G., Vaux, D. L., Wong, W. W-L. & Silke, J., 2016, In : Cancer Cell. 29, 2, p. 145 - 158 14 p.

Research output: Contribution to journalArticleResearchpeer-review

The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells

Saulep-Easton, D., Vincent, F. B., Quah, P. S., Wei, A., Ting, S. B., Croce, C. M., Tam, C. & Mackay, F., 2016, In : Leukemia. 30, 1, p. 163 - 172 10 p.

Research output: Contribution to journalArticleResearchpeer-review

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia

Brumatti, G., Ma, C., Lalaoui, N., Nguyen, N. Y., Navarro, M., Tanzer, M. C., Richmond, J., Ghisi, M., Salmon, J. M., Silke, N., Pomilio, G., Glaser, S. P., de Valle, E., Gugasyan, R., Gurthridge, M. A., Condon, S. M., Johnstone, R. W., Lock, R., Salvesen, G. S., Wei, A. & 3 othersVaux, D. L., Ekert, P. G. & Silke, J., 18 May 2016, In : Science Translational Medicine. 8, 339, 339ra69.

Research output: Contribution to journalArticleResearchpeer-review

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

Kotschy, A., Szlavik, Z., Murray, J., Davidson, J., Maragno, A. L., Le Toumelin-Braizat, G., Chanrion, M., Kelly, G. L., Gong, J. N., Moujalled, D. M., Bruno, A., Csekei, M., Paczal, A., Szabo, Z. B., Sipos, S., Radics, G., Proszenyak, A., Balint, B., Ondi, L., Blasko, G. & 2 othersPomilio, G. & Wei, A. H., 2016, In : Nature. 538, 7626, p. 477-482 6 p.

Research output: Contribution to journalArticleResearchpeer-review

2015

ABT-199 partners with azacitidine to contest myeloid malignancies

Wei, A., 2015, In : Leukemia and Lymphoma. 56, 1, p. 8 - 9 2 p.

Research output: Contribution to journalArticleOther

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Pham, T., Patil, S., Fleming, S. A., Avery, S., Walker, P. A., Wei, A., Curtis, D. J., Stuart, G., Klarica, D., O'Brien, M., Morris, K., Das, T. P., Bollard, G. M., Muirhead, J., Coutsouvelis, J. & Spencer, A., 2015, In : Transfusion. 55, 11, p. 2709 - 2713 5 p.

Research output: Contribution to journalArticleResearchpeer-review

Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9

Phillipson, L. J., Segal, D., Nero, T. L., Parker, M. W., Wan, S. S., de Silva, M., Guthridge, M. A., Wei, A. & Burns, C. J., 2015, In : Bioorganic & Medicinal Chemistry. 23, 19 (Art. No: 12539), p. 6280 - 6296 17 p.

Research output: Contribution to journalArticleResearchpeer-review

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee, E. M., Yee, D., Busfield, S. J., McManus, J. F., Cummings, N. J., Vairo, G., Wei, A., Ramshaw, H. S., Powell, J. A., Lopez, A. F., Lewis, I. D., McCall, M. N. & Lock, R. B., 2015, In : Haematologica: the hematology journal. 100, 7, p. 914 - 926 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling, V., Lee, D., McQuilten, Z., Avery, S., Low, M., Cody, S. H., Nguyen, N-T., McLean, C. A., Gorniak, M. B., Wei, A. & Ting, S. B. N., 1 Dec 2015, In : American Journal of Hematology. 90, 12, p. E219-E220 2 p.

Research output: Contribution to journalLetterOther

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML

Rijal, S., Fleming, S., Cummings, N., Rynkiewicz, N., Ooms, L. M., Nguyen, N-Y. N., Teh, T-C., Avery, S., McManus, J., Papenfuss, A. T., McLean, C. A., Guthridge, M. A., Mitchell, C. A. & Wei, A., 30 Apr 2015, In : Blood. 125, 18, p. 2815-2824 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei, A., Tan, P. T. G., Perruzza, S. N., Govindaraj, C., Fleming, S. A., McManus, J. F., Avery, S., Patil, S., Stevenson, W. C., Plebanski, M. & Spencer, A., 2015, In : British Journal of Haematology. 169, 2, p. 199 - 210 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Protocol of a multi-centre randomised controlled trial of a web-based information intervention with nurse-delivered telephone support for haematological cancer patients and their support persons

Bryant, J., Sanson-Fisher, R. W., Stevenson, W., Smits, R., Henskens, F., Wei, A., Tzelepis, F., D'Este, C. A., Paul, C. L. & Carey, M., 2015, In : BMC Cancer. 15, (Art. No: 295), p. 1 - 13 13 p.

Research output: Contribution to journalArticleOther

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study

Ravandi, F., Ritchie, E. K., Sayar, H., Lancet, J. E., Craig, M. D., Vey, N., Strickland, S. A., Schiller, G. J., Jabbour, E., Erba, H. P., Pigneux, A., Horst, H-A., Recher, C., Klimek, V. M., Cortes, J., Roboz, G. J., Odenike, O., Thomas, X., Havelange, V., Maertens, J. & 16 othersDerigs, H-G., Heuser, M., Damon, L., Powell, B. L., Gaidano, G., Carella, A-M., Wei, A., Hogge, D., Craig, A. R., Fox, J. A., Ward, R., Smith, J. A., Acton, G., Mehta, C., Stuart, R. K. & Kantarjian, H. M., 30 Jul 2015, In : Lancet Oncology. 16, 9, p. 1025 - 1036 12 p.

Research output: Contribution to journalArticleResearchpeer-review

2014

Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia

Saulep, D., Vincent, F., Le Page, M., Wei, A., Ting, S. B. N., Croce, C. M., Tam, C. & Mackay-Fisson, F., 2014, In : Leukemia. 28, 10, p. 2005 - 2015 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

Tan, P., Wei, A., Mithraprabhu, S., Cummings, N. J., Liu, H. B., Perugini, M., Reed, K. D., Avery, S., Patil, S., Walker, P. A., Mollee, P. N., Grigg, A. P., D'Andrea, R. J., Dear, A. E. & Spencer, A., 2014, In : Blood Cancer Journal. 4, 1, p. 1 - 8 8 p., e170.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Erratum: Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia (Blood Cancer Journal (2014) 4 (e237) DOI: 10.1038/bcj.2014.59)

Cummins, K. D., Jane, S. M., Ninkovic, S., Bazargan, A., Filshie, R. J. A., Sutrave, G., Hertzberg, M., Scott, A., Lane, S., Yannakou, C. K., Ritchie, P. D., D'Rozario, J., Black, J., Bavishi, K. & Wei, A., 1 Jan 2014, In : Blood Cancer Journal. 4, 9, e246.

Research output: Contribution to journalComment / DebateOtherpeer-review

Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care

Iland, H. J., Wei, A. & Seymour, J. F., 2014, In : Best Practice and Research in Clinical Haematology. 27, 1, p. 39 - 52 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia

Fedele, P., Avery, S., Patil, S., Spencer, A., Haas, M. & Wei, A., 2014, In : Internal Medicine Journal. 44, 8, p. 757 - 763 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients

Govindaraj, C., Madondo, M., Kong, Y. Y., Tan, P., Wei, A. & Plebanski, M., 2014, In : American Journal of Hematology. 89, 8, p. 795 - 802 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Optimal approach for high-risk acute promyelocytic leukemia

Iland, H. J., Seymour, J. F. & Wei, A., 2014, In : Current Opinion in Hematology. 21, 2, p. 102 - 113 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients

Govindaraj, C., Tan, P., Walker, P. A., Wei, A., Spencer, A. & Plebanski, M., 2014, In : Clinical Cancer Research. 20, 3, p. 724 - 735 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma

Campbell, P., Walker, P. A., Avery, S., Curtis, D. J., Schwarer, A., Wei, A., Kalff, A., Muirhead, J. L. & Spencer, A., 2014, In : Blood Cancer Journal. 4, 5, p. e213 - e213 3 p.

Research output: Contribution to journalLetterOther